|1.||Booij, Jan: 8 articles (12/2013 - 09/2002)|
|2.||Booij, J: 7 articles (03/2008 - 05/2000)|
|3.||Walker, Zuzana: 6 articles (02/2015 - 04/2007)|
|4.||Pappatà, Sabina: 6 articles (11/2014 - 03/2004)|
|5.||McKeith, Ian G: 6 articles (01/2009 - 06/2004)|
|6.||O'Brien, John T: 6 articles (01/2009 - 06/2004)|
|7.||Tinazzi, Michele: 5 articles (12/2015 - 10/2008)|
|8.||Barone, Paolo: 5 articles (11/2014 - 03/2004)|
|9.||Pellecchia, Maria Teresa: 5 articles (11/2014 - 03/2004)|
|10.||Grosset, Donald G: 5 articles (07/2012 - 09/2003)|
06/01/2007 - "To assess the utility of the appearances of occipital lobe perfusion on HMPAO SPECT in the diagnosis of dementia with Lewy bodies (DLB) using the 123I-FP-CIT findings as the diagnostic 'gold standard'. "
12/15/2015 - "We searched MEDLINE, CENTRAL and ClinicalTrials.gov to identify studies reporting enough data to determine accuracy measure of 123I-FP-CIT SPECT in differentiating between DLB and other dementia syndromes. "
03/01/2012 - "A systematic meta-analysis of published studies on the diagnostic accuracy of presynaptic dopaminergic imaging with ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies (DLB). "
03/01/2012 - "Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies."
12/15/2015 - "123I-FP-CIT SPECT can represent an accurate method to differentiate between DLB and other dementia syndromes. "
|2.||Parkinson Disease (Parkinson's Disease)
06/01/2013 - "The aim of this study was to evaluate the feasibility of FP-CIT PET template-based quantitative analysis on F-18 FP-CIT PET in patients with de novo Parkinson's disease (PD), compared with MR-based and manual methods. "
11/01/2012 - "Accuracy of subjective and objective handwriting assessment for differentiating Parkinson's disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs): an FP-CIT-validated study."
04/01/2012 - "Then, a sample of 49 Jewish Israeli Parkinson's disease (PD) patients with available neuroimaging ([(123)I]-FP-CIT-SPECT) data was analyzed, to study association of confirmed AIP SNPs with level of dopaminergic deficits in the putamen. "
12/01/2011 - "The purpose of this study was to investigate the diagnostic value of dual time point F-18 FP-CIT PET imaging in idiopathic Parkinson's disease (PD). "
04/01/2010 - "Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study."
|3.||Parkinsonian Disorders (Parkinsonism)
06/01/2011 - "Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images."
07/01/2014 - "To assess a group of patients with parkinsonism using serial studies with FP-CIT, basically the initial false negative results. "
11/01/2013 - "The objective of the present study was to study whether non-fluent/agrammatic patients without parkinsonism at baseline present decreased striatal 123I-FP-CIT uptake. "
07/01/2012 - "Study 1 was a trial of [(123)I]FP-CIT SPECT in patients with early suspected parkinsonism that compared baseline scans to the consensus clinical diagnosis established 3 years later. "
10/15/2011 - "The comparison between the results of FP-CIT and clinical manifestations showed: 4 patients with parkinsonism (PK) and pathological study; 4 without PK and normal study; 1 with PK and normal study and 1 without PK and pathological study. "
|4.||Movement Disorders (Movement Disorder)
01/01/2015 - "We analyzed 516 files of subjects with movement disorders who were consecutively examined using [(123)I]-FP-CIT scan and determined whether the use of imaging was appropriate and if it improved clinical diagnosis or care of the patient. "
01/01/2014 - "¹²³I-FP-CIT (DaTSCAN) SPECT studies of the nigrostriatal pathway are a valuable tool in the diagnosis of movement disorders. "
04/01/2013 - "Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al."
04/01/2013 - "Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study."
12/01/2012 - "Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study."
05/01/2000 - "Visual assessment of [123I]-FP-CIT SPECT images is an easily applied diagnostic test which is helpful in the differential diagnosis of tremor disorders and in confirming a clinical diagnosis of a hypokinetic-rigid syndrome."
01/01/2011 - "In a second part of the study, we retrospectively reviewed SPECT with FP-CIT data and confirmed the lack of correlation between dopaminergic loss and tremor by comparing DAT binding values of 82 PD subjects with bilateral tremor (n = 27), unilateral tremor (n = 22), and no tremor (n = 33). "
10/01/2014 - "The mean FP-CIT caudate nucleus uptake and the left caudate nucleus uptake were higher in PD patients with tremor than in PD patients without tremor (mean 9.0 % higher, left 10.5 % higher; p < 0.05), whereas there were no differences between tremor and non-tremor control patients. "
12/01/2013 - "The reduced [18F] FP-CIT uptake was significantly associated with earlier age-at-onset of tremor and asymmetric presentation of resting tremor. "
11/01/2011 - "123I-FP-CIT uptake was higher in the ipsilateral caudate (P=0.0050) and putamen (P=0.0012) of tremor type patients compared to akinetic-rigid type patients. "
|1.||Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)
|2.||3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamide
|5.||diazenedicarboxylic acid bis(N'-methylpiperazide)
|6.||Antipsychotic Agents (Antipsychotics)
|7.||Levodopa (L Dopa)
|1.||Mesenchymal Stem Cell Transplantation
|3.||Gamma Cameras (Gamma Camera)